What is Allogene Therapeutics Inc?
a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases. It develops a pipeline of multiple allogeneic CAR T cell product candidates utilizing protein engineering, gene editing, gene insertion, and advanced proprietary T cell manufacturing technologies. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 217.48M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 136,342 shares $49k | 0 |
| 3-6months | 129,697 shares $63k | 0 |
| 6-9months | 572,183 shares $178k | 0 |
| 9-12months | 7215,855 shares $378k | 0 |